Eagle Harbor Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Eagle Harbor Asset Management's BMY Position: Q3 2026 in Review
Eagle Harbor Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 1.3% in Q3 2026, selling an estimated $19.8K and leaving 24,539 shares worth $1.53M. The position accounts for 1.15% of the portfolio, ranked #20.
Eagle Harbor Asset Management first reported a position in BMY in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.73M in Q1 2025. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Eagle Harbor Asset Management held 24,539 shares of Bristol-Myers Squibb worth $1.53M as of Q3 2026.
- Eagle Harbor Asset Management sold 313 Bristol-Myers Squibb shares in Q3 2026, an estimated $19.8K.
- Bristol-Myers Squibb made up 1.15% of Eagle Harbor Asset Management's portfolio in Q3 2026, its #20 holding.
- Eagle Harbor Asset Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 20 quarters since.
- Eagle Harbor Asset Management's Bristol-Myers Squibb position peaked at $1.73M in Q1 2025.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Eagle Harbor Asset Management's 13F filing for Q3 2026, filed 21 Oct 2026.